Insider Trading › SGEN › Insiders
SGEN
SGEN·Insider activity
$228.74
+0.00 (+0.00%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
SGEN
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SGENS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of SGEN were filed in the last 180 days. Newest filing Nov 13, 2023 (2 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by SGEN insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
2,089Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of SGEN common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
2,089 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Epstein David RCEO · Director | Sale | −10.6K | $213.01 | $2.3M | 136.6Kdirect | Nov 10, 2023 | Nov 13, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −218 | $213.88 | $47K | 42.6Kdirect | Nov 9, 2023 | Nov 13, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −8,567 | $213.31 | $1.8M | 42.8Kdirect | Nov 9, 2023 | Nov 13, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −71 | $206.50 | $15K | 116.7Kdirect | Sep 21, 2023 | Sep 22, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −80 | $206.50 | $17K | 51.4Kdirect | Sep 21, 2023 | Sep 22, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −64 | $206.50 | $13K | 84.4Kdirect | Sep 21, 2023 | Sep 22, 2023 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial U.S. | Sale | −45 | $206.50 | $9K | 69.1Kdirect | Sep 21, 2023 | Sep 22, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −80 | $206.50 | $17K | 128.7Kdirect | Sep 21, 2023 | Sep 22, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −8,785 | $205.76 | $1.8M | 51.4Kdirect | Sep 7, 2023 | Sep 8, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −4,029 | $206.97 | $834K | 111.8Kdirect | Aug 31, 2023 | Sep 1, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,795 | $206.97 | $372K | 51.4Kdirect | Aug 31, 2023 | Sep 1, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −1,893 | $206.97 | $392K | 84.5Kdirect | Aug 31, 2023 | Sep 1, 2023 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial U.S. | Sale | −555 | $206.97 | $115K | 69.2Kdirect | Aug 31, 2023 | Sep 1, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −2,122 | $206.97 | $439K | 128.8Kdirect | Aug 31, 2023 | Sep 1, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −1,016 | $206.00 | $209K | 115.8Kdirect | Aug 29, 2023 | Aug 30, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −371 | $206.00 | $76K | 53.2Kdirect | Aug 29, 2023 | Aug 30, 2023 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial U.S. | Sale | −438 | $206.00 | $90K | 69.7Kdirect | Aug 29, 2023 | Aug 30, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −485 | $206.00 | $100K | 130.9Kdirect | Aug 29, 2023 | Aug 30, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −405 | $206.00 | $83K | 86.4Kdirect | Aug 29, 2023 | Aug 30, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,610 | $209.08 | $337K | 10.7Kindirect | Aug 28, 2023 | Aug 29, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,812 | $209.01 | $379K | 6,794direct | Aug 28, 2023 | Aug 29, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,503 | $209.16 | $314K | 8,606direct | Aug 28, 2023 | Aug 29, 2023 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial U.S. | Sale | −708 | $192.46 | $136K | 59.1Kdirect | Jul 3, 2023 | Jul 5, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −16.2K | $195.29 | $3.2M | 43.8Kdirect | Jun 7, 2023 | Jun 9, 2023 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial U.S. | Sale | −349 | $189.86 | $66K | 59.8Kdirect | May 16, 2023 | May 18, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,864 | $200.02 | $373K | 6,253direct | May 15, 2023 | May 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −5,835 | $200.07 | $1.2M | 12.3Kindirect | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −351 | $200.07 | $70K | 6,253direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −3,462 | $200.10 | $693K | 6,604direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −3,171 | $200.05 | $634K | 6,604direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,888 | $200.05 | $378K | 6,604direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −4,890 | $200.06 | $978K | 18.2Kindirect | May 1, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −295 | $200.06 | $59K | 6,604direct | May 1, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,990 | $200.12 | $398K | 6,899direct | May 1, 2023 | May 3, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −5,150 | $200.04 | $1.0M | 6,899direct | May 1, 2023 | May 3, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −5,000 | $205.86 | $1.0M | 86.8Kdirect | Apr 17, 2023 | Apr 19, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −10.0K | $205.95 | $2.1M | 99.4Kdirect | Apr 17, 2023 | Apr 19, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −40.4K | $204.74 | $8.3M | 118.9Kdirect | Apr 10, 2023 | Apr 12, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −15.0K | $204.14 | $3.1M | 118.9Kdirect | Apr 10, 2023 | Apr 12, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −243 | $205.86 | $50K | 118.9Kdirect | Apr 6, 2023 | Apr 7, 2023 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial U.S. | Sale | −133 | $205.86 | $27K | 60.1Kdirect | Apr 6, 2023 | Apr 7, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −174 | $205.86 | $36K | 86.8Kdirect | Apr 6, 2023 | Apr 7, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −243 | $205.86 | $50K | 68.8Kdirect | Apr 6, 2023 | Apr 7, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −333 | $205.86 | $69K | 99.4Kdirect | Apr 6, 2023 | Apr 7, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −4,284 | $202.54 | $868K | 12.3Kindirect | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −3,317 | $201.51 | $668K | 16.6Kindirect | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −3,124 | $200.45 | $626K | 19.9Kindirect | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,082 | $202.54 | $219K | 4,149direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −851 | $201.51 | $171K | 5,231direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −817 | $200.45 | $164K | 6,082direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −112 | $203.05 | $23K | 6,899direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −7,158 | $202.51 | $1.4M | 6,899direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −5 | $202.49 | $1K | 6,899direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −3,575 | $201.59 | $721K | 6,899direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −5,680 | $200.71 | $1.1M | 6,899direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −995 | $200.11 | $199K | 6,899direct | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −5,000 | $199.90 | $1.0M | 85.1Kdirect | Mar 16, 2023 | Mar 17, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,246 | $200.05 | $249K | 23.1Kindirect | Mar 15, 2023 | Mar 17, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −320 | $200.05 | $64K | 6,899direct | Mar 15, 2023 | Mar 17, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −2,037 | $200.05 | $408K | 7,219direct | Mar 15, 2023 | Mar 17, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −10.0K | $199.81 | $2.0M | 96.9Kdirect | Mar 15, 2023 | Mar 17, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −288 | $200.00 | $58K | 24.3Kindirect | Mar 14, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −470 | $200.00 | $94K | 13.0Kdirect | Mar 14, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −74 | $200.00 | $15K | 13.0Kdirect | Mar 14, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −173 | $202.36 | $35K | 24.6Kindirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −808 | $201.53 | $163K | 24.8Kindirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −8,210 | $200.20 | $1.6M | 25.6Kindirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −5,758 | $200.06 | $1.2M | 7,219direct | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −44 | $202.35 | $9K | 13.1Kdirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −214 | $201.53 | $43K | 13.1Kdirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −2,098 | $200.20 | $420K | 13.3Kdirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −7,629 | $200.30 | $1.5M | 15.4Kdirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −1,348 | $201.53 | $272K | 15.4Kdirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| WELCH DANIEL GDirector | Sale | −283 | $202.36 | $57K | 15.4Kdirect | Mar 13, 2023 | Mar 16, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −6,082 | $177.37 | $1.1M | 117.2Kdirect | Mar 9, 2023 | Mar 10, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −26.4K | $176.71 | $4.7M | 123.3Kdirect | Mar 9, 2023 | Mar 10, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −10.3K | $175.89 | $1.8M | 149.7Kdirect | Mar 9, 2023 | Mar 10, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −2,691 | $177.92 | $479K | 67.3Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −13.5K | $177.07 | $2.4M | 67.3Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −20.0K | $182.53 | $3.7M | 117.2Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −39.9K | $160.00 | $6.4M | 137.2Kdirect | Feb 16, 2023 | Feb 21, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −5,000 | $155.00 | $775K | 85.1Kdirect | Feb 16, 2023 | Feb 21, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −2,615 | $141.04 | $369K | 96.9Kdirect | Feb 15, 2023 | Feb 17, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −7,185 | $140.55 | $1.0M | 99.5Kdirect | Feb 15, 2023 | Feb 17, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −200 | $138.62 | $28K | 106.7Kdirect | Feb 15, 2023 | Feb 17, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −783 | $138.52 | $108K | 96.9Kdirect | Feb 2, 2023 | Feb 3, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident, R&D & CMO | Sale | −10.0K | $135.00 | $1.4M | 97.5Kdirect | Jan 24, 2023 | Jan 26, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −5,000 | $135.03 | $675K | 85.1Kdirect | Jan 24, 2023 | Jan 26, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −578 | $130.71 | $76K | 85.1Kdirect | Jan 17, 2023 | Jan 19, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident R&D & CMO | Sale | −7,500 | $135.00 | $1.0M | 97.5Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −4,525 | $135.00 | $611K | 85.7Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| DANSEY ROGER DPresident R&D & CMO | Sale | −2,500 | $135.00 | $338K | 97.5Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −475 | $135.00 | $64K | 85.7Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial U.S. | Sale | −1,129 | $127.63 | $144K | 58.5Kdirect | Dec 20, 2022 | Dec 21, 2022 | Form 4 ↗ |
| DANSEY ROGER DPresident, Research and Develo | Sale | −9,403 | $135.00 | $1.3M | 97.5Kdirect | Dec 14, 2022 | Dec 16, 2022 | Form 4 ↗ |
| DANSEY ROGER DPresident, Research and Develo | Sale | −597 | $135.00 | $81K | 97.5Kdirect | Dec 14, 2022 | Dec 16, 2022 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −8,333 | $131.05 | $1.1M | 85.7Kdirect | Nov 17, 2022 | Nov 18, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −7,500 | $129.10 | $968K | 40.3Kdirect | Nov 11, 2022 | Nov 15, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −2,204 | $135.00 | $298K | 97.5Kdirect | Oct 17, 2022 | Oct 19, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −3,189 | $135.00 | $431K | 97.5Kdirect | Oct 17, 2022 | Oct 19, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −4,607 | $135.00 | $622K | 97.5Kdirect | Oct 17, 2022 | Oct 19, 2022 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −2,064 | $154.41 | $319K | 137.2Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −2,122 | $154.41 | $328K | 139.2Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,789 | $154.41 | $276K | 67.2Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,795 | $154.41 | $277K | 69.0Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −555 | $154.41 | $86K | 59.6Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −578 | $154.41 | $89K | 60.2Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −4,029 | $154.41 | $622K | 97.5Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −184 | $154.41 | $28K | 101.6Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −806 | $154.41 | $124K | 101.8Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −1,893 | $154.41 | $292K | 84.4Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −1,755 | $154.41 | $271K | 86.3Kdirect | Aug 31, 2022 | Sep 1, 2022 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −1,106 | $170.22 | $188K | 141.4Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −861 | $170.22 | $147K | 142.5Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −988 | $170.22 | $168K | 60.7Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −777 | $170.22 | $132K | 61.7Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −717 | $170.22 | $122K | 88.0Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −922 | $170.22 | $157K | 88.8Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −869 | $170.22 | $148K | 70.8Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −658 | $170.22 | $112K | 71.6Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −1,848 | $170.22 | $315K | 102.6Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| DANSEY ROGER DInterim CEO & CMO | Sale | −2,406 | $170.22 | $410K | 104.4Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −712 | $179.46 | $128K | 48.8Kdirect | Jul 5, 2022 | Jul 7, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −14.9K | $180.00 | $2.7M | 62.1Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −735 | $180.00 | $132K | 77.0Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −735 | $180.00 | $132K | 77.0Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −913 | $180.00 | $164K | 77.0Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −17.4K | $180.00 | $3.1M | 77.0Kdirect | Jun 28, 2022 | Jun 30, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,134 | $160.00 | $181K | 119.5Kindirect | Jun 17, 2022 | Jun 22, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,273 | $138.61 | $176K | 59.1Kdirect | May 24, 2022 | May 26, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,298 | $137.51 | $178K | 59.1Kdirect | May 24, 2022 | May 26, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −8,295 | $136.40 | $1.1M | 59.1Kdirect | May 24, 2022 | May 26, 2022 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −333 | $134.21 | $45K | 49.5Kdirect | May 16, 2022 | May 18, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −10.6K | $125.39 | $1.3M | 666.1Kdirect | May 12, 2022 | May 13, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −6,450 | $126.18 | $814K | 666.1Kdirect | May 12, 2022 | May 13, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −652 | $144.15 | $94K | 77.0Kdirect | Apr 21, 2022 | Apr 22, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −1,885 | $144.32 | $272K | 666.1Kdirect | Apr 20, 2022 | Apr 22, 2022 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −567 | $144.32 | $82K | 127.9Kdirect | Apr 20, 2022 | Apr 22, 2022 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −401 | $144.32 | $58K | 75.9Kdirect | Apr 20, 2022 | Apr 22, 2022 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −319 | $144.32 | $46K | 49.8Kdirect | Apr 20, 2022 | Apr 22, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −574 | $144.32 | $83K | 59.1Kdirect | Apr 20, 2022 | Apr 22, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −787 | $144.32 | $114K | 77.6Kdirect | Apr 20, 2022 | Apr 22, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −690 | $145.08 | $100K | 46.3Kdirect | Apr 19, 2022 | Apr 21, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −1,516 | $144.17 | $219K | 46.3Kdirect | Apr 19, 2022 | Apr 21, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −1,794 | $143.32 | $257K | 46.3Kdirect | Apr 19, 2022 | Apr 21, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −474 | $157.23 | $75K | 667.9Kdirect | Apr 7, 2022 | Apr 8, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −1,900 | $156.48 | $297K | 667.9Kdirect | Apr 7, 2022 | Apr 8, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −3,828 | $155.83 | $597K | 667.9Kdirect | Apr 7, 2022 | Apr 8, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −2,400 | $154.36 | $370K | 667.9Kdirect | Apr 7, 2022 | Apr 8, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −4,692 | $153.38 | $720K | 667.9Kdirect | Apr 7, 2022 | Apr 8, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −2,100 | $152.59 | $320K | 667.9Kdirect | Apr 7, 2022 | Apr 8, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −1,649 | $151.42 | $250K | 667.9Kdirect | Apr 7, 2022 | Apr 8, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −4,000 | $135.62 | $542K | 667.9Kdirect | Mar 7, 2022 | Mar 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −6,643 | $134.74 | $895K | 667.9Kdirect | Mar 7, 2022 | Mar 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −2,400 | $133.69 | $321K | 667.9Kdirect | Mar 7, 2022 | Mar 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −3,900 | $132.72 | $518K | 667.9Kdirect | Mar 7, 2022 | Mar 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −100 | $136.33 | $14K | 667.9Kdirect | Mar 7, 2022 | Mar 9, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,157 | $127.67 | $148K | 59.5Kdirect | Mar 3, 2022 | Mar 4, 2022 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −10.8K | $126.98 | $1.4M | 59.5Kdirect | Mar 3, 2022 | Mar 4, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −300 | $141.56 | $42K | 667.9Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −4,084 | $140.83 | $575K | 667.9Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −8,985 | $139.96 | $1.3M | 667.9Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −3,574 | $138.97 | $497K | 667.9Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −100 | $137.29 | $14K | 667.9Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −2,371 | $139.42 | $331K | 46.3Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −1,029 | $138.66 | $143K | 46.3Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −1,100 | $137.45 | $151K | 46.3Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −703 | $136.14 | $96K | 78.2Kdirect | Feb 3, 2022 | Feb 4, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −739 | $137.58 | $102K | 78.9Kdirect | Feb 2, 2022 | Feb 4, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −214 | $124.23 | $27K | 46.3Kdirect | Jan 28, 2022 | Feb 1, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −883 | $123.39 | $109K | 46.3Kdirect | Jan 28, 2022 | Feb 1, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −2,553 | $122.43 | $313K | 46.3Kdirect | Jan 28, 2022 | Feb 1, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −850 | $121.69 | $103K | 46.3Kdirect | Jan 28, 2022 | Feb 1, 2022 | Form 4 ↗ |
| GRYSKA DAVID WDirector | Sale | −4,500 | $135.24 | $609K | 46.3Kdirect | Jan 14, 2022 | Jan 19, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −8,163 | $143.91 | $1.2M | 667.9Kdirect | Jan 7, 2022 | Jan 11, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −4,560 | $144.82 | $660K | 667.9Kdirect | Jan 7, 2022 | Jan 11, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −3,221 | $145.84 | $470K | 667.9Kdirect | Jan 7, 2022 | Jan 11, 2022 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −1,100 | $147.16 | $162K | 667.9Kdirect | Jan 7, 2022 | Jan 11, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −1,735 | $152.58 | $265K | 79.7Kdirect | Jan 3, 2022 | Jan 5, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −3,470 | $152.58 | $529K | 81.4Kdirect | Jan 3, 2022 | Jan 5, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −3,470 | $152.58 | $529K | 84.9Kdirect | Jan 3, 2022 | Jan 5, 2022 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −280 | $155.58 | $44K | 88.4Kdirect | Dec 21, 2021 | Dec 22, 2021 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −1,129 | $149.85 | $169K | 50.0Kdirect | Dec 20, 2021 | Dec 22, 2021 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −194 | $149.85 | $29K | 51.1Kdirect | Dec 20, 2021 | Dec 22, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −345 | $149.85 | $52K | 59.5Kdirect | Dec 20, 2021 | Dec 22, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −280 | $149.85 | $42K | 88.6Kdirect | Dec 20, 2021 | Dec 22, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −1,227 | $149.85 | $184K | 667.9Kdirect | Dec 20, 2021 | Dec 22, 2021 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −345 | $149.85 | $52K | 128.5Kdirect | Dec 20, 2021 | Dec 22, 2021 | Form 4 ↗ |
| LIU JEAN IChief Legal Officer | Sale | −276 | $149.85 | $41K | 70.4Kdirect | Dec 20, 2021 | Dec 22, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −5,348 | $150.38 | $804K | 669.2Kdirect | Dec 7, 2021 | Dec 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −11.5K | $149.56 | $1.7M | 669.2Kdirect | Dec 7, 2021 | Dec 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −14.7K | $148.27 | $2.2M | 669.2Kdirect | Dec 7, 2021 | Dec 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −12.2K | $147.83 | $1.8M | 669.2Kdirect | Dec 7, 2021 | Dec 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −1,650 | $146.54 | $242K | 669.2Kdirect | Dec 7, 2021 | Dec 9, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −51.4K | $161.39 | $8.3M | 42.9Mindirect | Dec 1, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −4,738 | $161.39 | $765K | 4.1Mindirect | Dec 1, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −8,332 | $161.35 | $1.3M | 43.0Mindirect | Dec 1, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −768 | $161.35 | $124K | 4.1Mindirect | Dec 1, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −25.8K | $160.80 | $4.2M | 43.0Mindirect | Dec 1, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −2,381 | $160.80 | $383K | 4.1Mindirect | Dec 1, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −1,007 | $165.68 | $167K | 43.0Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −93 | $165.68 | $15K | 4.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −9,618 | $164.82 | $1.6M | 43.0Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −886 | $164.82 | $146K | 4.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −1,337 | $163.39 | $218K | 43.0Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −123 | $163.39 | $20K | 4.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −20.2K | $160.96 | $3.2M | 43.0Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −1,858 | $160.96 | $299K | 4.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −29.4K | $160.53 | $4.7M | 43.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −2,713 | $160.53 | $436K | 4.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −5,860 | $160.08 | $938K | 43.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −540 | $160.08 | $86K | 4.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −208.6K | $160.00 | $33.4M | 43.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Baker Brothers Life Sciences LPDirector · 10% owner | Sale | −19.2K | $160.00 | $3.1M | 4.1Mindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −617 | $179.84 | $111K | 59.8Kdirect | Nov 11, 2021 | Nov 12, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −3,366 | $178.82 | $602K | 60.5Kdirect | Nov 11, 2021 | Nov 12, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −2,017 | $177.94 | $359K | 63.8Kdirect | Nov 11, 2021 | Nov 12, 2021 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −40.2K | $185.00 | $7.4M | 126.6Kdirect | Nov 3, 2021 | Nov 5, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Afairs | Sale | −6,222 | $179.14 | $1.1M | 69.1Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Afairs | Sale | −14.5K | $178.07 | $2.6M | 75.3Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Afairs | Sale | −8,776 | $177.29 | $1.6M | 89.8Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Afairs | Sale | −753 | $175.08 | $132K | 98.5Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Afairs | Sale | −2,588 | $174.20 | $451K | 99.3Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Afairs | Sale | −2,080 | $173.00 | $360K | 101.9Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −33.6K | $180.00 | $6.0M | 126.6Kdirect | Oct 29, 2021 | Nov 2, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −6,000 | $150.00 | $900K | 57.5Kdirect | Sep 8, 2021 | Sep 10, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −169 | $167.52 | $28K | 85.3Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −741 | $167.52 | $124K | 85.5Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −3,701 | $167.52 | $620K | 86.2Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −4,787 | $167.52 | $802K | 668.5Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −9,564 | $167.52 | $1.6M | 673.2Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Legal Affairs | Sale | −1,755 | $167.52 | $294K | 68.9Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Legal Affairs | Sale | −1,893 | $167.52 | $317K | 70.7Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −2,122 | $167.52 | $355K | 126.4Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −1,865 | $167.52 | $312K | 128.6Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,795 | $167.52 | $301K | 57.5Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,789 | $167.52 | $300K | 59.3Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −555 | $167.52 | $93K | 51.2Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −578 | $167.52 | $97K | 51.7Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −8,662 | $170.27 | $1.5M | 682.8Kdirect | Aug 31, 2021 | Aug 31, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −1,770 | $168.19 | $298K | 691.5Kdirect | Aug 31, 2021 | Aug 31, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −2,906 | $167.62 | $487K | 693.2Kdirect | Aug 30, 2021 | Aug 31, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −32.8K | $166.79 | $5.5M | 696.1Kdirect | Aug 30, 2021 | Aug 31, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −2,081 | $170.16 | $354K | 728.9Kdirect | Aug 27, 2021 | Aug 31, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −12.2K | $168.86 | $2.1M | 731.0Kdirect | Aug 27, 2021 | Aug 31, 2021 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −777 | $154.55 | $120K | 42.4Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −2,789 | $154.55 | $431K | 712.4Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −658 | $154.55 | $102K | 52.4Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −1,657 | $154.55 | $256K | 72.8Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Affairs | Sale | −718 | $154.55 | $111K | 63.3Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| SIMPSON TODD EChief Financial Officer | Sale | −533 | $154.55 | $82K | 119.3Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −100 | $157.25 | $16K | 74.4Kdirect | Aug 13, 2021 | Aug 13, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −9,900 | $156.58 | $1.6M | 74.5Kdirect | Aug 13, 2021 | Aug 13, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −3,676 | $159.26 | $585K | 715.2Kdirect | Aug 6, 2021 | Aug 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −2,117 | $160.46 | $340K | 715.2Kdirect | Aug 6, 2021 | Aug 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −7,185 | $162.02 | $1.2M | 715.2Kdirect | Aug 5, 2021 | Aug 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −9,262 | $163.10 | $1.5M | 715.2Kdirect | Aug 5, 2021 | Aug 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −4,813 | $163.80 | $788K | 715.2Kdirect | Aug 5, 2021 | Aug 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident & CEO · Director | Sale | −2,300 | $164.77 | $379K | 715.2Kdirect | Aug 5, 2021 | Aug 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −5,191 | $155.70 | $808K | 715.2Kdirect | Jul 2, 2021 | Jul 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −7,412 | $156.43 | $1.2M | 715.2Kdirect | Jul 2, 2021 | Jul 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −2,355 | $157.31 | $370K | 715.2Kdirect | Jul 2, 2021 | Jul 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −310 | $158.29 | $49K | 715.2Kdirect | Jul 2, 2021 | Jul 6, 2021 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −703 | $158.41 | $111K | 43.2Kdirect | Jul 2, 2021 | Jul 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −4,488 | $156.94 | $704K | 715.2Kdirect | Jul 1, 2021 | Jul 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −6,165 | $157.92 | $974K | 715.2Kdirect | Jul 1, 2021 | Jul 6, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −3,432 | $158.64 | $544K | 715.2Kdirect | Jul 1, 2021 | Jul 6, 2021 | Form 4 ↗ |
| DANSEY ROGER DChief Medical Officer | Sale | −25.1K | $152.22 | $3.8M | 84.4Kdirect | Jun 16, 2021 | Jun 21, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,303 | $150.00 | $195K | 53.0Kdirect | Jun 7, 2021 | Jun 8, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −1,843 | $142.07 | $262K | 715.2Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −5,718 | $142.99 | $818K | 715.2Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −8,675 | $143.81 | $1.2M | 715.2Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −3,900 | $144.90 | $565K | 715.2Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −4,551 | $145.73 | $663K | 715.2Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −3,866 | $147.00 | $568K | 715.2Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −800 | $147.71 | $118K | 715.2Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,391 | $147.82 | $206K | 53.0Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −900 | $147.05 | $132K | 54.4Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −2,800 | $145.98 | $409K | 55.3Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,288 | $144.61 | $186K | 58.1Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −2,318 | $143.35 | $332K | 59.4Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −2,000 | $142.42 | $285K | 61.7Kdirect | Jun 3, 2021 | Jun 4, 2021 | Form 4 ↗ |
| ROMP CHARLES REVP, Commercial | Sale | −334 | $145.95 | $49K | 43.9Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| LIU JEAN IGC/EVP, Leg Affairs | Sale | −1,061 | $140.00 | $149K | 64.1Kdirect | May 11, 2021 | May 13, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −7,723 | $134.29 | $1.0M | 715.2Kdirect | May 6, 2021 | May 7, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −18.1K | $135.11 | $2.4M | 715.2Kdirect | May 6, 2021 | May 7, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −3,551 | $135.75 | $482K | 715.2Kdirect | May 6, 2021 | May 7, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −6,101 | $141.42 | $863K | 715.2Kdirect | Apr 9, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −5,192 | $142.22 | $738K | 715.2Kdirect | Apr 9, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −1,009 | $143.24 | $145K | 715.2Kdirect | Apr 9, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −300 | $143.95 | $43K | 715.2Kdirect | Apr 9, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −9,167 | $144.40 | $1.3M | 715.2Kdirect | Apr 8, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −2,545 | $145.43 | $370K | 715.2Kdirect | Apr 8, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −4,739 | $146.41 | $694K | 715.2Kdirect | Apr 8, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −300 | $147.15 | $44K | 715.2Kdirect | Apr 8, 2021 | Apr 9, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −11.4K | $144.92 | $1.7M | 715.2Kdirect | Mar 4, 2021 | Mar 5, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −9,447 | $145.58 | $1.4M | 715.2Kdirect | Mar 4, 2021 | Mar 5, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −6,000 | $146.72 | $880K | 715.2Kdirect | Mar 4, 2021 | Mar 5, 2021 | Form 4 ↗ |
| SIEGALL CLAY BPresident and CEO · Director | Sale | −2,497 | $147.68 | $369K | 715.2Kdirect | Mar 4, 2021 | Mar 5, 2021 | Form 4 ↗ |
| HIMES VAUGHN BChief Technical Officer | Sale | −1,992 | $154.23 | $307K | 129.9Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →